-
Something wrong with this record ?
Substantially elevated C-reactive protein (CRP), together with low levels of procalcitonin (PCT), contributes to diagnosis of fungal infection in immunocompromised patients
M. Marková, H. Brodská, K. Malíčková, V. Válková, P. Cetkovský, M. Kolář, M. Haluzík,
Language English Country Germany
Document type Journal Article, Research Support, Non-U.S. Gov't
Grant support
NT13899
MZ0
CEP Register
NLK
ProQuest Central
from 1997-01-01 to 2017-12-31
CINAHL Plus with Full Text (EBSCOhost)
from 2008-01-11 to 1 year ago
Medline Complete (EBSCOhost)
from 2007-01-01 to 1 year ago
Nursing & Allied Health Database (ProQuest)
from 1997-01-01 to 2017-12-31
Health & Medicine (ProQuest)
from 1997-01-01 to 2017-12-31
- MeSH
- Bacterial Infections blood immunology MeSH
- C-Reactive Protein metabolism MeSH
- Adult MeSH
- Hematologic Neoplasms blood immunology microbiology MeSH
- Fever blood immunology microbiology MeSH
- Immunocompromised Host MeSH
- Calcitonin blood MeSH
- Middle Aged MeSH
- Humans MeSH
- Young Adult MeSH
- Mycoses blood immunology MeSH
- Graft vs Host Disease blood immunology microbiology MeSH
- Predictive Value of Tests MeSH
- Protein Precursors blood MeSH
- ROC Curve MeSH
- Aged MeSH
- Hematopoietic Stem Cell Transplantation MeSH
- Check Tag
- Adult MeSH
- Middle Aged MeSH
- Humans MeSH
- Young Adult MeSH
- Male MeSH
- Aged MeSH
- Female MeSH
- Publication type
- Journal Article MeSH
- Research Support, Non-U.S. Gov't MeSH
PURPOSE: Serum procalcitonin (PCT) has become a routinely utilized parameter with a high prediction value of the severity of bacterial infectious complications and their immediate outcomes. Whereas the utility of PCT in differentiating between bacterial and viral infection is generally accepted, its significance in fungal infections has yet to be determined. The aim of the study was to determine the role of PCT testing in patients at high risk for invasive fungal infections. METHODS: Immunocompromised hematological patients undergoing cyclic chemotherapy treatment or allogeneic hemopoietic stem cell transplantation with infectious complications in which the infectious agents were identified during the disease course were evaluated. In patients with bacterial infection, positive hemocultures were documented, and in patients with fungal infection, the presence of either proven or probable disease was confirmed according to Ascioglu criteria. C-reactive protein (CRP) and PCT were prospectively assessed from the day following fever onset, for four consecutive days. RESULTS: Overall, 34 patients were evaluated, 21 with bacterial and 13 with fungal infections. Significant elevations of CRP concentrations (i.e., above the upper normal limit) were observed in all patients, with a tendency toward higher levels in bacterial (both gram-positive [Gr+] and Gr-negative [Gr-]) than in fungal infections. PCT levels were significantly elevated in patients with bacterial infections (e.g., predominantly in Gr- compared to Gr+), whereas in patients with fungal infections, we identified minimal or no PCT elevations, p < 0.01. For the fungal infections, according to constructed receiver operating characteristic curves, a combination of PCT <0.5 μg/L and CRP 100-300 mg/L offers the best specificity, sensitivity and positive and negative predictive values (81, 85, 73, and 89 %, respectively). CONCLUSION: Altogether, our data suggest that the finding of substantially elevated CRP combined with low PCT in immunocompromised patients may indicate systemic fungal infection. The use of this combination might simplify the diagnostic process, which otherwise can often be lengthy and arduous.
References provided by Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc14064168
- 003
- CZ-PrNML
- 005
- 20191025090425.0
- 007
- ta
- 008
- 140704s2013 gw f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.1007/s00520-013-1844-1 $2 doi
- 035 __
- $a (PubMed)23712521
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a gw
- 100 1_
- $a Marková, Markéta $u Institute of Haematology and Blood Transfusion, 1st Faculty of Medicine of Charles University in Prague, U nemocnice 1, Praha 2, 128 20, Czech Republic, marketa.markova@uhkt.cz. $7 xx0101281
- 245 10
- $a Substantially elevated C-reactive protein (CRP), together with low levels of procalcitonin (PCT), contributes to diagnosis of fungal infection in immunocompromised patients / $c M. Marková, H. Brodská, K. Malíčková, V. Válková, P. Cetkovský, M. Kolář, M. Haluzík,
- 520 9_
- $a PURPOSE: Serum procalcitonin (PCT) has become a routinely utilized parameter with a high prediction value of the severity of bacterial infectious complications and their immediate outcomes. Whereas the utility of PCT in differentiating between bacterial and viral infection is generally accepted, its significance in fungal infections has yet to be determined. The aim of the study was to determine the role of PCT testing in patients at high risk for invasive fungal infections. METHODS: Immunocompromised hematological patients undergoing cyclic chemotherapy treatment or allogeneic hemopoietic stem cell transplantation with infectious complications in which the infectious agents were identified during the disease course were evaluated. In patients with bacterial infection, positive hemocultures were documented, and in patients with fungal infection, the presence of either proven or probable disease was confirmed according to Ascioglu criteria. C-reactive protein (CRP) and PCT were prospectively assessed from the day following fever onset, for four consecutive days. RESULTS: Overall, 34 patients were evaluated, 21 with bacterial and 13 with fungal infections. Significant elevations of CRP concentrations (i.e., above the upper normal limit) were observed in all patients, with a tendency toward higher levels in bacterial (both gram-positive [Gr+] and Gr-negative [Gr-]) than in fungal infections. PCT levels were significantly elevated in patients with bacterial infections (e.g., predominantly in Gr- compared to Gr+), whereas in patients with fungal infections, we identified minimal or no PCT elevations, p < 0.01. For the fungal infections, according to constructed receiver operating characteristic curves, a combination of PCT <0.5 μg/L and CRP 100-300 mg/L offers the best specificity, sensitivity and positive and negative predictive values (81, 85, 73, and 89 %, respectively). CONCLUSION: Altogether, our data suggest that the finding of substantially elevated CRP combined with low PCT in immunocompromised patients may indicate systemic fungal infection. The use of this combination might simplify the diagnostic process, which otherwise can often be lengthy and arduous.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a senioři $7 D000368
- 650 _2
- $a bakteriální infekce $x krev $x imunologie $7 D001424
- 650 _2
- $a C-reaktivní protein $x metabolismus $7 D002097
- 650 _2
- $a kalcitonin $x krev $7 D002116
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a horečka $x krev $x imunologie $x mikrobiologie $7 D005334
- 650 _2
- $a nemoc štěpu proti hostiteli $x krev $x imunologie $x mikrobiologie $7 D006086
- 650 _2
- $a hematologické nádory $x krev $x imunologie $x mikrobiologie $7 D019337
- 650 _2
- $a transplantace hematopoetických kmenových buněk $7 D018380
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a imunokompromitovaný pacient $7 D016867
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a mykózy $x krev $x imunologie $7 D009181
- 650 _2
- $a prediktivní hodnota testů $7 D011237
- 650 _2
- $a proteinové prekurzory $x krev $7 D011498
- 650 _2
- $a ROC křivka $7 D012372
- 650 _2
- $a mladý dospělý $7 D055815
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Lahoda Brodská, Helena, $d 1959- $7 jn20000400273
- 700 1_
- $a Černá, Karin $7 xx0096040
- 700 1_
- $a Válková, Veronika $7 xx0182654
- 700 1_
- $a Cetkovský, Petr, $d 1959- $7 xx0025652
- 700 1_
- $a Kolář, Michal
- 700 1_
- $a Haluzík, Martin, $d 1970- $7 xx0000707
- 773 0_
- $w MED00004456 $t Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer $x 1433-7339 $g Roč. 21, č. 10 (2013), s. 2733-2742
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/23712521 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20140704 $b ABA008
- 991 __
- $a 20191025090901 $b ABA008
- 999 __
- $a ok $b bmc $g 1031652 $s 862900
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2013 $b 21 $c 10 $d 2733-2742 $i 1433-7339 $m Supportive care in cancer $n Support Care Cancer $x MED00004456
- GRA __
- $a NT13899 $p MZ0
- LZP __
- $a Pubmed-20140704